The United States has provided updated information in relation to the epidemiological situation on its territory as regards HPAI that gave rise to the suspension of the entry of certain products into the Union, as set out in Annexes V and XIV to Implementing Regulation (EU) 2021/404.
Recital 12, Regulation (EU) 2023/1664
In forcesince 25 Aug 2023